221 related articles for article (PubMed ID: 30279229)
21. Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells.
Remstein ED; Hanson CA; Kyle RA; Hodnefield JM; Kurtin PJ
Semin Oncol; 2003 Apr; 30(2):182-6. PubMed ID: 12720133
[TBL] [Abstract][Full Text] [Related]
22. Microarray demonstrates different gene expression profiling signatures between Waldenström macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.
Trojani A; Greco A; Tedeschi A; Lodola M; Di Camillo B; Ricci F; Turrini M; Varettoni M; Rattotti S; Morra E
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):208-10. PubMed ID: 23477935
[TBL] [Abstract][Full Text] [Related]
23. Angiogenesis in Waldenstrom's macroglobulinemia.
Rajkumar SV; Hayman S; Greipp PR
Semin Oncol; 2003 Apr; 30(2):262-4. PubMed ID: 12720149
[TBL] [Abstract][Full Text] [Related]
24. Identification of 2 DNA methylation subtypes of Waldenström macroglobulinemia with plasma and memory B-cell features.
Roos-Weil D; Giacopelli B; Armand M; Della-Valle V; Ghamlouch H; Decaudin C; Metzner M; Lu J; Le Garff-Tavernier M; Leblond V; Vyas P; Zenz T; Nguyen-Khac F; Bernard OA; Oakes CC
Blood; 2020 Jul; 136(5):585-595. PubMed ID: 32457988
[TBL] [Abstract][Full Text] [Related]
25. Sequence and expression analyses of mu and delta transcripts in patients with Waldenström's macroglobulinemia.
Shiokawa S; Suehiro Y; Uike N; Muta K; Nishimura J
Am J Hematol; 2001 Nov; 68(3):139-43. PubMed ID: 11754393
[TBL] [Abstract][Full Text] [Related]
26. The malignant clone in Waldenstrom's macroglobulinemia.
Kriangkum J; Taylor BJ; Mant MJ; Treon SP; Belch AR; Pilarski LM
Semin Oncol; 2003 Apr; 30(2):132-5. PubMed ID: 12720122
[TBL] [Abstract][Full Text] [Related]
27. Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemia.
Roccaro AM; Leleu X; Sacco A; Moreau AS; Hatjiharissi E; Jia X; Xu L; Ciccarelli B; Patterson CJ; Ngo HT; Russo D; Vacca A; Dammacco F; Anderson KC; Ghobrial IM; Treon SP
Clin Cancer Res; 2008 Mar; 14(6):1849-58. PubMed ID: 18347188
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase-8 is overexpressed in Waldenström's macroglobulinemia cells, and specific inhibition of this metalloproteinase blocks release of soluble CD27.
Zhou Y; Liu X; Xu L; Tseng H; Cao Y; Jiang J; Ciccarelli BT; Yang G; Patterson CJ; Hunter ZR; Treon SP
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):172-5. PubMed ID: 21856553
[TBL] [Abstract][Full Text] [Related]
29. Origins of Waldenstrom's macroglobulinemia: does it arise from an unusual B-cell precursor?
Kriangkum J; Taylor BJ; Reiman T; Belch AR; Pilarski LM
Clin Lymphoma; 2005 Mar; 5(4):217-9. PubMed ID: 15794851
[TBL] [Abstract][Full Text] [Related]
30. Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance.
Rollett RA; Wilkinson EJ; Gonzalez D; Fenton JA; Short MA; Evans PA; Rawstron AC; Owen RG
Clin Lymphoma Myeloma; 2006 Jul; 7(1):70-2. PubMed ID: 16879773
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts.
Hodge LS; Elsawa SF; Grote DM; Price-Troska TL; Asmann YW; Fonseca R; Gertz MA; Witzig TE; Novak AJ; Ansell SM
Blood Cancer J; 2011 Jun; 1(6):e24. PubMed ID: 22829168
[TBL] [Abstract][Full Text] [Related]
32. The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions.
Sacco A; Fenotti A; Affò L; Bazzana S; Russo D; Presta M; Malagola M; Anastasia A; Motta M; Patterson CJ; Rossi G; Imberti L; Treon SP; Ghobrial IM; Roccaro AM
Oncotarget; 2017 May; 8(21):35435-35444. PubMed ID: 28423722
[TBL] [Abstract][Full Text] [Related]
33. Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Burnworth B; Wang Z; Singleton TP; Bennington A; Fritschle W; Bennington R; Brodersen LE; Wells DA; Loken MR; Zehentner BK
Leuk Res; 2016 Dec; 51():41-48. PubMed ID: 27890075
[TBL] [Abstract][Full Text] [Related]
34. The Wayne State University Waldenstrom's Macroglobulinemia preclinical model for Waldenstrom's macroglobulinemia.
Al-Katib AM; Mensah-Osman E; Aboukameel A; Mohammad R
Semin Oncol; 2003 Apr; 30(2):313-7. PubMed ID: 12720160
[TBL] [Abstract][Full Text] [Related]
35. Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemia.
Hunter ZR; Xu L; Yang G; Tsakmaklis N; Vos JM; Liu X; Chen J; Manning RJ; Chen JG; Brodsky P; Patterson CJ; Gustine J; Dubeau T; Castillo JJ; Anderson KC; Munshi NM; Treon SP
Blood; 2016 Aug; 128(6):827-38. PubMed ID: 27301862
[TBL] [Abstract][Full Text] [Related]
36. Immunotherapeutic strategies for the treatment of plasma cell malignancies.
Treon SP; Raje N; Anderson KC
Semin Oncol; 2000 Oct; 27(5):598-613. PubMed ID: 11049026
[TBL] [Abstract][Full Text] [Related]
37. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
Vitolo U; Ferreri AJ; Montoto S
Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
[TBL] [Abstract][Full Text] [Related]
38. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
Owen RG
Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
[TBL] [Abstract][Full Text] [Related]
39. Waldenström's macroglobulinemia: Two malignant clones in a monoclonal disease? Molecular background and clinical reflection.
Growková K; Kryukova E; Kufová Z; Filipová J; Ševčíková T; Říhová L; Kaščák M; Kryukov F; Hájek R
Eur J Haematol; 2017 Dec; 99(6):469-478. PubMed ID: 28886236
[TBL] [Abstract][Full Text] [Related]
40. Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development.
Zhan F; Tian E; Bumm K; Smith R; Barlogie B; Shaughnessy J
Blood; 2003 Feb; 101(3):1128-40. PubMed ID: 12393520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
